Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06318546
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-03-13
Brief Title:
Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Efficacy of Dexmedetomidine as Adjuvant to Intrathecal Bupivacaine in Decreasing Incidence of Post Spinal Shivering in Parturients Undergoing Caesarean Section
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will test the effects of intrathecal dexmedetomidine as adjuvant to intrathecal bupivacaine and its direct effect in decreasing incidence of post spinal shivering in Parturients Undergoing Caesarean section
Detailed Description:
APreoperative settings
All patients will be assessed preoperatively by careful history taking full physical examination and laboratory evaluation An informed written consent will be taken from every patient just before the surgery
BIntraoperative and postoperative settings
On arrival to the operating room baseline parameters such as ECG mean arterial blood pressure heart rate and oxygen saturation will be recorded Intravenous line will be inserted and IV Ringers solution will be started 500ml bolus will be given as a preload over 20 min before performing spinal anaesthesia and maintenance volume of 10mlkg
For each group patients will be put in sitting position the procedure will be performed under complete aseptic precautions local anaesthesia will be administered by infiltration of the skin and subcutaneous tissues with 3-5 ml lidocaine 1 at L3-L4 and A 25-G needle will be used
Both groups will be given 22ml 11-12 mg hyperbaric Bupivacaine hydrochloride 05
All patients will be assessed preoperatively by careful history taking full physical examination and laboratory evaluation An informed written consent will be taken from every patient just before the surgery
BIntraoperative and postoperative settings
On arrival to the operating room baseline parameters such as ECG mean arterial blood pressure heart rate and oxygen saturation will be recorded Intravenous line will be inserted and IV Ringers solution will be started 500ml bolus will be given as a preload over 20 min before performing spinal anaesthesia and maintenance volume of 10mlkg
For each group patients will be put in sitting position the procedure will be performed under complete aseptic precautions local anaesthesia will be administered by infiltration of the skin and subcutaneous tissues with 3-5 ml lidocaine 1 at L3-L4 and A 25-G needle will be used
Both groups will be given 22ml 11-12 mg hyperbaric Bupivacaine hydrochloride 05
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None